L-Glutamine



Compound IDCDAMM00027
Common nameL-Glutamine
IUPAC name(2S)-2,5-diamino-5-oxopentanoic acid
Molecular formulaC5H10N2O3

Experimental data

Retention time6.33
Adduct[M+H]+
Actual mz147.077
Theoretical mz147.076
Error4.63
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score8.6119

Identifiers and class information

Inchi keyZDXPYRJPNDTMRX-VKHMYHEASA-N
SmilesC(CC(=O)N)C(C(=O)O)N
SuperclassOrganic acids and derivatives
ClassCarboxylic acids and derivatives

Pharmacokinetic properties

Number of descriptor values(#stars)4
Number of non-conjugated amine groups (#amine)1
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)1
Number of non-conjugated amide groups (#amide)1
Number of rotatable bonds (#rotor)5
Number of reactive functional groups (#rtvFG)0
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)146.146
Computed dipole moment(dipole)3.465
Total solvent accessible surface area (SASA)339.544
Hydrophobic component of SASA (FOSA)79.647
Hydrophilic component of SASA (FISA)259.896
Pie component of the SASA (PISA)0
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)519.611
Number of hydrogen bond donors (donorHB)5
Number of hydrogen bond acceptors (accptHB)5.5
Free energy of solvation of dipole (dip^2/V)0.0231102
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0362203
Globularity descriptor (glob)0.920565
Predicted polarizability in cubic angstroms (QPpolrz)11.43
Predicted hexadecane/gas partition coefficient (QPlogPC16)6.061
Predicted octanol/gas partition coefficient (QPlogPoct)14.104
Predicted water/gas partition coefficient (QPlogPw)16.715
Predicted octanol/water partition coefficient (QPlogPo/w)-4.196
Predicted aqueous solubility (QPlogS)1.225
Conformation-independent predicted aqueous solubility (CIQPlogS)1.029
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-0.362
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)1.08
Predicted brain/blood partition coefficient (QPlogBB)-1.384
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)0.909
Predicted skin permeability, log Kp (QPlogKp)-7.892
PM3 calculated ionization potential (IP(ev))9.973
PM3 calculated electron affinity (EA(eV))-1.019
Number of likely metabolic reactions (#metab)5
Prediction of binding to human serum albumin (QPlogKhsa)-1.393
Predicted qualitative human oral absorption (HumanOralAbsorption)1
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)2.977
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)37.476
Van der Waals surface area (PSA)127.319
Number of nitrogen and oxygen atoms (#NandO)5
Number of violations of Lipinski’s rule of five (RuleOfFive)0
Number of violations of Jorgensen’s rule of three (RuleOfThree)1

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P29475NOS1Nitric-oxide synthase, brainT16117SEA
P35228NOS2Nitric oxide synthase, inducibleT02703SEA
P29474NOS3Nitric-oxide synthase, endothelialT06046SEA
P09960LTA4HLeukotriene A4 hydrolaseT03691SEA
Q14833GRM4Metabotropic glutamate receptor 4T99402SEA
O00222GRM8Metabotropic glutamate receptor 8T77548SEA
P43005SLC1A1Excitatory amino acid transporter 3T31721SEA
P39086GRIK1Glutamate receptor ionotropic kainate 1T73495SEA
Q13002GRIK2Glutamate receptor ionotropic kainate 2T58178SEA
O15303GRM6Metabotropic glutamate receptor 6T55956SEA
P42261GRIA1Glutamate receptor ionotropic, AMPA 1T33584SEA
Q16478GRIK5Glutamate receptor ionotropic kainate 5T87930SEA
Q13003GRIK3Glutamate receptor ionotropic kainate 3T68876SEA
P42262GRIA2Glutamate receptor ionotropic, AMPA 2T42392SEA
Q9H4A4RNPEPAminopeptidase BT57818SEA
P11926ODC1Ornithine decarboxylaseT60366SEA
P07101THTyrosine 3-hydroxylaseT62390SEA
Q16719KYNUKynureninaseT99912SEA
Q07075ENPEPAminopeptidase AT31956SEA
Q01650SLC7A5L-type amino acid transporter 1 (by homology)T48330SEA
P09211GSTP1Glutathione S-transferase PiT21669SEA
P08263GSTA1Glutathione S-transferase A1T17221SEA
Q9Y3Q0NAALAD2NAALADase IIT70036SEA
Q92820GGHGamma-glutamyl hydrolaseT71646SEA
Q04760GLO1Glyoxalase IT88285SEA
P05089ARG1Arginase-1 (by homology)T63224SEA
Q9UPC5GPR34Probable G-protein coupled receptor 34T73859SEA
O00398P2RY10Putative P2Y purinoceptor 10T00488SEA
Q9BXC1GPR174Probable G-protein coupled receptor 174T87661SEA
P09210GSTA2Glutathione S-transferase A2T53510SEA
Q9UPY5SLC7A11Cystine/glutamate transporterT11615SEA
Q04609FOLH1Glutamate carboxypeptidase IIT97071SEA
Q9BWQ3ASCT2Alanine/serine/cysteine transporter 2T59493SEA
P00480OTCOrnithine transcarbamylaseT52098SEA
P42263GRIA3Glutamate receptor AMPA 3T62391SEA
Q16348PEPT2Solute carrier family 15 member 2T52067SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T16117DI0173Headache[ICD-11: 8A80-8A84]P29475NOS1
T16117DI0264Migraine[ICD-11: 8A80]P29475NOS1
T02703DI0083Chronic kidney disease[ICD-11: GB61]P35228NOS2
T02703DI0320Osteoarthritis[ICD-11: FA00-FA05]P35228NOS2
T02703DI0375Sepsis[ICD-11: 1G40-1G41]P35228NOS2
T02703DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]P35228NOS2
T06046DI0287Myocardial infarction[ICD-11: BA41-BA43]P29474NOS3
T03691DI0012Acute myeloid leukaemia[ICD-11: 2A60]P09960LTA4H
T99402DI0331Parkinsonism[ICD-11: 8A00]Q14833GRM4
T73495DI0134Epilepsy/seizure[ICD-11: 8A61-8A6Z]P39086GRIK1
T73495DI0396Substance abuse[ICD-11: 6C40]P39086GRIK1
T33584DI0298Neuropathy[ICD-11: 8C0Z]P42261GRIA1
T42392DI0298Neuropathy[ICD-11: 8C0Z]P42262GRIA2
T60366DI0020African trypanosomiasis[ICD-11: 1F51]P11926ODC1
T62390DI0019Adrenomedullary hyperfunction[ICD-11: 5A75]P07101TH
T62390DI0306Nutritional deficiency[ICD-11: 5B50-5B71]P07101TH
T99912DI0046Bacterial infection[ICD-11: 1A00-1C4Z]Q16719KYNU
T99912DI0062Breast cancer[ICD-11: 2C60-2C6Y]Q16719KYNU
T31956DI0190Hypertension[ICD-11: BA00-BA04]Q07075ENPEP
T21669DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]P09211GSTP1
T88285DI0210Influenza[ICD-11: 1E30-1E32]Q04760GLO1
T63224DI0258Metabolism inborn error[ICD-11: 5C50]P05089ARG1
T11615DI0054Body-focused behaviour disorder[ICD-11: 6B25]Q9UPY5SLC7A11
T97071DI0122Diagnostic imaging[ICD-11: N.A.]Q04609FOLH1
T97071DI0346Prostate cancer[ICD-11: 2C82]Q04609FOLH1
T52098DI0258Metabolism inborn error[ICD-11: 5C50]P00480OTC
T62391DI0298Neuropathy[ICD-11: 8C0Z]P42263GRIA3

Copyright © 2025